The present study explores the prognostic survival value of pretreatment health-related quality of life (HRQOL) and changes in HRQOL following whole-brain radiation treatment in patients with brain metastases.
Browsing: CNS Oncology
This review explores the current literature on SRS treatment for both metastatic and benign intradural tumors, with a focus on differential use for intramedullary and intradural extramedullary neoplasms.
In this review, the authors discuss driving factors for the next generation of immunotherapy and target therapy, as well as how to increase the accuracy of the selection process for these therapies.
Karmakar & Reilly review what is known about the role of NF1 mutation in immune cell function & the role of immune cells in promoting tumorigenesis in NF1.
In this article, the authors report the case of a patient suffering from a melanoma with multiple brain metastasis, treated with BRAF and MEK double blockade, with impressive and rapid response.
This summary guideline outlines methods for starting patients on TTFields, for monitoring patient response to therapy and provides a framework for evaluating when therapy should be re-planned.
This review discusses targeted therapies for glioblastoma and different attempts to identify biomarkers of response to drugs.
Glioblastoma provides a good opportunity for evaluation of immunotherapy as a targeted treatment for patients.
This review explores the role of the transcription factor, termed SOX2, in brain tumors, focusing specifically on studies of glioblastoma and medulloblastoma.